NDC 50844-963-09 - Flu HBP Maximum Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50844-963
- Requested NDC
- 50844-963-09
- Package NDCs from labels
- 50844-963-09
- Manufacturer
- L.N.K. International, Inc. | LNK International, Inc.
- Effective date
- 2020-02-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LNK 44-738 | L.N.K. International, Inc. | LNK International, Inc. | 2020-02-07 | HUMAN OTC DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 45N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4335c8-596f-3269-e063-6294a90a6c3d | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 46W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43404e-bdab-3f4b-e063-6294a90ab881 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 47N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f435148-dcb1-cfdf-e063-6394a90aa8b6 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 50N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43610f-6c4f-dd9d-e063-6394a90ab60a | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| Childrens Mucus and Cough Relief | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Chain Drug Manufacturing Assn | 06822a28-3f82-471d-8db5-c5981b263a03 | 2026-10-30 | Warnings | 9D2RTI9KYH |
| Quality Choice Severe Cold and Cough Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | Chain Drug Manufacturing Assn | ce658dd5-b683-436e-b16b-0c06f6f87fd9 | 2026-10-30 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 9cdfa6fb-4bc5-4a54-93fc-edd84bf80ef3 | 2026-10-30 | Warnings | 362O9ITL9D |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | LEADER/ Cardinal Health 110, Inc. | b3773f02-02a9-33c8-e053-2995a90a2235 | 2026-10-30 | Warnings | 362O9ITL9D |
| Multi-Symptom Allergy | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Walgreen Company | 5170c450-989d-44fa-ab38-86c78feae3b6 | 2026-10-30 | Warnings | V1Q0O9OJ9Z 362O9ITL9D |
| tussin severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | H E B | 7cc2c136-d1b7-4658-99bb-73bb1d140261 | 2026-10-30 | Warnings | 9D2RTI9KYH 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | 6ec12573-03d6-40c1-9945-d345b401e062 | 2026-10-30 | Warnings | 362O9ITL9D |
| equaline childrens cold and cough | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | United Natural Foods, Inc. dba UNFI | a24021a0-ef68-4bce-ba53-d262d1025cc0 | 2026-10-30 | Warnings | 9D2RTI9KYH |
| 8HR Arthritis Pain | ACETAMINOPHEN | Demoulas Super Markets, Inc | 5e848565-1d58-5ebc-e063-6394a90adbfc | 2026-10-29 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Meijer | 181aee35-8fb2-35e4-e063-6394a90a6b3b | 2026-10-29 | Warnings | 362O9ITL9D |
| Mucus Relief DM Extended Release Caplets | GUAIFENESIN, DEXTROMETHORPHAN HBR | ATLANTIC BIOLOGICALS CORP. | 308f50dd-e8d6-0264-e063-6394a90afa68 | 2026-10-29 | Warnings | 9D2RTI9KYH |
| HERA BLACK CUSHION FOUNDATION 13N1 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | Amorepacific Corporation | 5aff3d25-d034-0815-e063-6294a90a8664 | 2026-10-29 | Warnings | 15FIX9V2JP |
| Menstrual Complete | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | Chain Drug Marketing Association, Inc. | 5f8f9644-48c5-4556-a0a4-7bdc9a629daa | 2026-10-29 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.